• slide-3
  • slide-4
  • slide-5
  • slide-6

Translating science into medicine
8th Annual Asian Oncology Summit
12th Annual Conference of the OOTR
Kyoto Breast Cancer Consensus Conference 2016

March 3-6, 2016 | Westin Miyako, Kyoto, Japan

Join international colleagues to discuss and enlighten the future direction of Asian cancer research and management at the 8th Asian Oncology Summit (AOS2016).

The 2016 event is colocated with the 12th Annual Conference of the Organisation for Oncology and Translational Research (OOTR) and the Kyoto Breast Cancer Consensus Conference (KBCCC) 2016.


One registration gives you access to all conference sessions:

AOS 2016 Sessions

  • State-of-the-art in surgical oncology
  • Precision oncology I: drug development
  • Precision oncology II: restoring the risk-benefit balance
  • State-of-the-art radiotherapy I & II
  • Immunotherapy I & II
  • Cancer survivorship (in conjunction with The Lancet Psychiatry and The Lancet Neurology)

AOS/OOTR Joint Sessions

  • Drug development in the genomic era
  • Hereditary cancer management in the genomic era

OOTR Sessions

  • Clinical trials
  • Genomic data—clinical applications and new drug/biomarker development
  • New therapeutic approaches with genomic data
  • Tumour-infiltrating lymphocytes
  • OOTR Seminar:  Arf6-AMAP1 pathway drives mesenchymal metastasis and drug resistance of cancers under RTK and GPCR signaling

KBCCC Sessions

  • New approaches for QOL
  • Axillary surgery versus radiotherapy
  • Ductal in situ carcinoma
  • Diagnostic imaging
  • Pre-emptive surgery and medical treatment
  • Breast axilla surgery
  • Issues in radiotherapy
  • Axillary imaging and treatment
  • Triple-negative breast cancer
  • Consensus Session 1: Ductal in situ carcinoma
  • Consensus Session 2: Management of the axilla

Grand Debate: Balance between local and systemic therapy
Policy Session: Big data and genomic oncology

Download the full programme here

Register Now More than 70 speakers View Programme

Click to download apps

Conference Committee
  • David Collingridge
    Chair, AOS 2016; Editor-in-Chief, The Lancet Oncology; Publishing Director, The Lancet Specialty Journals
  • Cassandra Coburn
    Vice Chair; AOS 2016; Deputy Editor, The Lancet Oncology
  • Masakazu Toi
    Chair, KBCCC 2016 and 12th OOTR Annual Conference; Director, KBCRN; President, OOTR; Professor, Kyoto University
  • Takashi Inamoto
    Chair: KBCCC 2016; Director, KBCRN
  • Chikako Yamauchi
    Chair: KBCCC 2016; Director, KBCRN
  • Louis Chow
    Chair, 12th OOTR Annual Conference; Executive Director, OOTR
Supporting Publication

Organised by
  • Elsevier
  • OOTR
  • The Lancet Oncology
Gold Sponsor
Bronze Sponsor
Genomic Health
Kyowa Kirin
  • IceCure Medical
  • IceCure Medical
Co-organised educational lecture
Full co-organiser of a talk for educational purpose for OOTR
  • Chugai
  • AstraZeneca
  • Eli Lilly
Full co-organiser of a talk for educational purpose for KBCCC
Partial co-organiser of a talk for educational purpose for OOTR
  • Eisai
  • Century Medical
Partial co-organiser of a talk for educational purpose for KBCCC
  • Hamamatsu
  • Sysmex
  • Shimadzu
Supporting Partners
  • ACOS
  • Asia-Pacific Psycho-Oncology Network
  • CSCO
  • Kyoto University
  • Kyoto University
  • Singapore Society of Oncology
Donators to OOTR
  • Sanofi
  • SRL
  • Pfizer
Donators to KBCCC
  • Daiichi-Sankyo
  • Taiho
  • Sanofi
  • ONO
  • Pfizer